Giorgio Ottaviani

1.3k total citations
22 papers, 635 citations indexed

About

Giorgio Ottaviani is a scholar working on Pharmacology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Giorgio Ottaviani has authored 22 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Pharmaceutical Science. Recurrent topics in Giorgio Ottaviani's work include Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hepatitis B Virus Studies (3 papers). Giorgio Ottaviani is often cited by papers focused on Analytical Chemistry and Chromatography (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hepatitis B Virus Studies (3 papers). Giorgio Ottaviani collaborates with scholars based in Switzerland, China and Italy. Giorgio Ottaviani's co-authors include Sophie Martel, Pierre‐Alain Carrupt, Bernard Faller, Stephane Rodde, Liping Zhou, Roberta Pacifici, M. Rosa, Simona Pichini, Ilaria Altieri and Rubén Alvarez‐Sánchez and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Journal of Hepatology.

In The Last Decade

Giorgio Ottaviani

21 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Ottaviani Switzerland 14 189 144 113 108 104 22 635
Shobha Bhattachar United States 15 216 1.1× 134 0.9× 104 0.9× 220 2.0× 278 2.7× 24 895
Rubén Alvarez‐Sánchez Switzerland 15 294 1.6× 94 0.7× 53 0.5× 74 0.7× 33 0.3× 24 728
V.G. Casabó Spain 17 168 0.9× 61 0.4× 49 0.4× 212 2.0× 134 1.3× 39 689
Marta Rui Italy 14 382 2.0× 242 1.7× 48 0.4× 43 0.4× 79 0.8× 27 752
Utpal Nandi India 17 377 2.0× 196 1.4× 88 0.8× 72 0.7× 252 2.4× 101 1.1k
Kimberley A. Lentz United States 14 199 1.1× 108 0.8× 108 1.0× 323 3.0× 78 0.8× 24 963
Stephanie A. Sweetana United States 10 115 0.6× 48 0.3× 34 0.3× 161 1.5× 32 0.3× 12 531
Eleftheria Tsakalozou United States 17 212 1.1× 31 0.2× 48 0.4× 269 2.5× 76 0.7× 47 763
Francesc Cabré Spain 18 293 1.6× 327 2.3× 67 0.6× 33 0.3× 331 3.2× 55 995
Susan Petusky United States 9 225 1.2× 126 0.9× 101 0.9× 66 0.6× 59 0.6× 10 567

Countries citing papers authored by Giorgio Ottaviani

Since Specialization
Citations

This map shows the geographic impact of Giorgio Ottaviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Ottaviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Ottaviani more than expected).

Fields of papers citing papers by Giorgio Ottaviani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Ottaviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Ottaviani. The network helps show where Giorgio Ottaviani may publish in the future.

Co-authorship network of co-authors of Giorgio Ottaviani

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Ottaviani. A scholar is included among the top collaborators of Giorgio Ottaviani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Ottaviani. Giorgio Ottaviani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhisen, Zheng Zhou, Zhiheng Xu, et al.. (2023). Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. Journal of Medicinal Chemistry. 66(20). 14116–14132. 5 indexed citations
2.
3.
Funk, Juergen, Martin Bopst, Giorgio Ottaviani, et al.. (2018). An innovative investigative approach to characterize the effects observed in a combined fertility study in male and female rats. Regulatory Toxicology and Pharmacology. 95. 339–347. 3 indexed citations
4.
Zhou, Xiaolei, Guo‐Min Yang, Weifeng Zhu, et al.. (2018). In vitro and in vivo antiviral characterization of RO7049389, a novel small molecule capsid assembly modulator for the treatment of chronic hepatitis B. Journal of Hepatology. 68. S770–S770. 11 indexed citations
5.
Chen, Mu, Wenzhe Lu, Lu Yang, et al.. (2017). An Ultra-Sensitive LC–MS/MS Method to Determine Midazolam Levels in Human Plasma: Development, Validation and Application to A Clinical Study. Bioanalysis. 9(3). 297–312. 5 indexed citations
6.
Obst-Sander, U., Bernd Kuhn, Simona Ceccarelli, et al.. (2016). Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(20). 5092–5097. 19 indexed citations
7.
Zhong, Sheng, Russell G. Jones, Wenzhe Lu, Simone Schadt, & Giorgio Ottaviani. (2015). A New Rapid In Vitro Assay for Assessing Reactivity of Acyl Glucuronides. Drug Metabolism and Disposition. 43(11). 1711–1717. 19 indexed citations
8.
Zoja, Carla, Monica Locatelli, Daniela Corna, et al.. (2015). Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy. ˜The œNephron journals/Nephron journals. 132(1). 59–69. 41 indexed citations
9.
Ottaviani, Giorgio, et al.. (2015). Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias. Regulatory Toxicology and Pharmacology. 73(2). 509–514. 5 indexed citations
10.
Ottaviani, Giorgio, et al.. (2015). Importance of Critical Micellar Concentration for the Prediction of Solubility Enhancement in Biorelevant Media. Molecular Pharmaceutics. 12(4). 1171–1179. 23 indexed citations
11.
Martin, Rainer E., Johannes D. Aebi, Bernd Kuhn, et al.. (2015). Discovery of 4-Aryl-5,6,7,8-tetrahydroisoquinolines as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors: In Vivo Evaluation in Rodents and Cynomolgus Monkeys. Journal of Medicinal Chemistry. 58(20). 8054–8065. 35 indexed citations
12.
Faller, Bernard, Giorgio Ottaviani, Peter Ertl, Giuliano Berellini, & Alan Collis. (2011). Evolution of the physicochemical properties of marketed drugs: can history foretell the future?. Drug Discovery Today. 16(21-22). 976–984. 35 indexed citations
13.
Ottaviani, Giorgio, et al.. (2010). What is modulating solubility in simulated intestinal fluids?. European Journal of Pharmaceutical Sciences. 41(3-4). 452–457. 86 indexed citations
14.
Pissot‐Soldermann, Carole, Marc Gerspacher, Pascal Furet, et al.. (2010). Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(8). 2609–2613. 33 indexed citations
15.
Ottaviani, Giorgio, Sophie Martel, & Pierre‐Alain Carrupt. (2007). In Silico and In Vitro Filters for the Fast Estimation of Skin Permeation and Distribution of New Chemical Entities. Journal of Medicinal Chemistry. 50(4). 742–748. 21 indexed citations
16.
Ottaviani, Giorgio, Sophie Martel, & Pierre‐Alain Carrupt. (2006). Parallel Artificial Membrane Permeability Assay:  A New Membrane for the Fast Prediction of Passive Human Skin Permeability. Journal of Medicinal Chemistry. 49(13). 3948–3954. 157 indexed citations
17.
Martel, Sophie, et al.. (2005). Experimental and Virtual Physicochemical and Pharmacokinetic Profiling of New Chemical Entities. CHIMIA International Journal for Chemistry. 59(6). 308–308. 9 indexed citations
18.
Benedetti, Paolo, Raimund Mannhold, Gabriele Cruciani, & Giorgio Ottaviani. (2004). GRIND/ALMOND investigations on CysLT1 receptor antagonists of the quinolinyl(bridged)aryl type. Bioorganic & Medicinal Chemistry. 12(13). 3607–3617. 22 indexed citations
19.
Rosa, M., Roberta Pacifici, Ilaria Altieri, et al.. (1992). How the steady-state cotinine concentration in cigarette smokers is directly related to nicotine intake. Clinical Pharmacology & Therapeutics. 52(3). 324–329. 43 indexed citations
20.
Pichini, Simona, Ilaria Altieri, Roberta Pacifici, et al.. (1992). Simultaneous determination of cotinine and trans-3′-hydroxycotinine in human serum by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 577(2). 358–361. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shobha Bhattachar Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by V.G. Casabó Breakdown of academic impact, for papers by Marta Rui Breakdown of academic impact, for papers by Utpal Nandi Breakdown of academic impact, for papers by Kimberley A. Lentz Breakdown of academic impact, for papers by Stephanie A. Sweetana Breakdown of academic impact, for papers by Eleftheria Tsakalozou Breakdown of academic impact, for papers by Francesc Cabré Breakdown of academic impact, for papers by Susan Petusky
Rankless by CCL
2026